Back to Trades
Dambkowski Carl
Chief Medical OfficerCIK 0001983476
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 14
- Buy transactions
- 0
- Sell transactions
- 23
- Companies
- 2
- Active
- 2025–2026
Dambkowski Carl, Chief Medical Officer, has filed 14 SEC reports (2025–2026), spread across 2 companies, totaling $25.3M in disclosed volume. Weighing $0 bought versus $16.0M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
14 loaded
| Jul 16 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | Gift | $0 |
| Jul 2 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | Sell | $730.1K |
| Jun 24 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | Sell | $3.5M |
| Jun 12 | ORKA Oruka Therapeutics, Inc. | Dambkowski Carl | Director | Sell | $2.5M |
| Jun 5 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | Sell | $432.9K |
| Jun 3 | ORKA Oruka Therapeutics, Inc. | Dambkowski Carl | Director | Award | $504.6K |
| May 22 | ORKA Oruka Therapeutics, Inc. | Dambkowski Carl | Director | Sell | $6.2M |
| May 8 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | Sell | $462.8K |
| Feb 4 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | Sell | $361.9K |
| Jan 9 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | Sell | $1.5M |
| Jan 6 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | Award | $6.3M |
| Oct 3 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | Sell | $203.4K |
| Sep 5 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | Sell | $103.2K |
| Aug 8 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | Sell | $103.0K |
14 filings